Health technology transfer
- 30 September 2000
- Vol. 321 (7264) , 817-820
- https://doi.org/10.1136/bmj.321.7264.817
Abstract
Global health relies on biomedical scientists and public health workers to solve infectious disease and other health problems at a local level. Yet investigators in developing countries face tremendous obstacles; scientific isolation, insufficient technical training and research tools, a lack of up to date scientific information, and limited financial, material, and human resources. To build local scientific capacity to monitor and control disease and to promote health, research on locally relevant issues must be supported and sustainable partnerships built to facilitate these efforts. We discuss key elements for transfer of technologies in health research and present two case studies of such programmes. #### Summary points More funding must be made available to scientists in developing countries and to organisations that support in-country training and research Genuine partnership and mutual trust is a prerequisite for the sustainable transfer of technology from developed to developing countries Building local scientific capacity and long term North-South and South-South partnerships are important in establishing effective health research programmes Research topics should have local relevance and priority, and technology transfer should be participatory, equitable, and sustained Autonomous research centres attract funding and reduce administrative burdens Though 93% of the world's burden of preventable mortality occurs in developing countries,1 too little research funding is targeted to health problems of developing countries, creating a dangerous funding differential.2 In addition, many modern laboratory technologies remain inaccessible in these nations. Both utilitarian and humanitarian arguments can be made for training scientists and health professionals in developing countries in the use of modern laboratory and epidemiological skills. It takes only a day or two for a pathogen to get from any one place on the planet to any other; thus, building capacity in developing countries is a necessary strategy for preventing the global spread of infectious agents.3 Additionally, as a matter …Keywords
This publication has 19 references indexed in Scilit:
- Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation ratesParasite Immunology, 1999
- 1. General introductionTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Rapid Subtyping of Dengue Viruses by Restriction Site-Specific (RSS)–PCRVirology, 1999
- Distinction of recrudescences from new infections by pcr‐rflp analysis in a comparative trial of cgp 56 697 and chloroquine in Tanzanian children.Tropical Medicine & International Health, 1998
- Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infantsThe Lancet, 1997
- Developing essential scientific capability in countries with limited resourcesNature Medicine, 1996
- Appropriate transfer of molecuar technology to latin america for publica health and biomedical scienceBiochemical Education, 1996
- Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern TanzaniaThe Lancet, 1994
- Developing health research capability in Tanzania: From a Swiss tropical institute field laboratory to the Ifakara centre of the tanzanian national institute of medical researchActa Tropica, 1994
- Community-Based Questionnaires and Health Statistics as Tools for the Cost-Efficient Identification of communities at Risk of Urinary SchistosomiasisInternational Journal of Epidemiology, 1991